Skip to main content

and
  1. Article

    Open Access

    Obinutuzumab in Combination with Chemotherapy for the First-Line Treatment of Patients with Advanced Follicular Lymphoma

    The National Institute for Health and Care Excellence (NICE), as part of the institute’s single technology appraisal (STA) process, invited the company that makes obinutuzumab (Roche Products Limited) to submi...

    Frederick W. Thielen, Nasuh C. Büyükkaramikli, Rob Riemsma in PharmacoEconomics (2019)

  2. No Access

    Article

    Long-term economic consequences of child maltreatment: a population-based study

    Child maltreatment is prognostically associated with long-term detrimental consequences for mental health. These consequences are reflected in higher costs due to health service utilization and productivity lo...

    Frederick W. Thielen, Margreet ten Have in European Child & Adolescent Psychiatry (2016)